Kezar Life Sciences Statistics Share Statistics Kezar Life Sciences has 7.31M
shares outstanding. The number of shares has increased by -89.99%
in one year.
Shares Outstanding 7.31M Shares Change (YoY) -89.99% Shares Change (QoQ) 0% Owned by Institutions (%) 59.24% Shares Floating 6.22M Failed to Deliver (FTD) Shares 13,167 FTD / Avg. Volume 27.4%
Short Selling Information The latest short interest is 371.68K, so 5.09% of the outstanding
shares have been sold short.
Short Interest 371.68K Short % of Shares Out 5.09% Short % of Float 5.2% Short Ratio (days to cover) 5.81
Valuation Ratios The PE ratio is -5.85 and the forward
PE ratio is -0.63.
Kezar Life Sciences's PEG ratio is
0.33.
PE Ratio -5.85 Forward PE -0.63 PS Ratio 0 Forward PS n/a PB Ratio 4.19 P/FCF Ratio -6.6 PEG Ratio 0.33
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kezar Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 6.76,
with a Debt / Equity ratio of 0.14.
Current Ratio 6.76 Quick Ratio 6.76 Debt / Equity 0.14 Debt / EBITDA -0.2 Debt / FCF -0.22 Interest Coverage -56.88
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.52M Employee Count 55 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -93.35% in the
last 52 weeks. The beta is 0.65, so Kezar Life Sciences's
price volatility has been higher than the market average.
Beta 0.65 52-Week Price Change -93.35% 50-Day Moving Average 4.38 200-Day Moving Average 5.57 Relative Strength Index (RSI) 39.13 Average Volume (20 Days) 48,051
Income Statement
Revenue n/a Gross Profit n/a Operating Income -90.61M Net Income -83.74M EBITDA -81.1M EBIT -85.33M Earnings Per Share (EPS) -1.15
Full Income Statement Balance Sheet The company has 41.75M in cash and 16.18M in
debt, giving a net cash position of 25.57M.
Cash & Cash Equivalents 41.75M Total Debt 16.18M Net Cash 25.57M Retained Earnings -434.5M Total Assets 125.26M Working Capital 103.36M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -74.21M
and capital expenditures -29K, giving a free cash flow of -74.24M.
Operating Cash Flow -74.21M Capital Expenditures -29K Free Cash Flow -74.24M FCF Per Share -1.02
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields KZR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for KZR is $9,
which is 129% higher than the current price. The consensus rating is "Hold".
Price Target $9 Price Target Difference 129% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 30, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 30, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -5.29 Piotroski F-Score 3
